Article Details

Risk Adjusted Net Present Value: What is the current valuation of United Therapeutics's Ralinepag

Retrieved on: 2024-12-13 19:45:16

Tags for this article:

Click the tags to see associated articles and topics

Risk Adjusted Net Present Value: What is the current valuation of United Therapeutics's Ralinepag. View article details on hiswai:

Excerpt

... monoclonal antibody for oncologic applications, are the other products. Its product candidates include monoclonal antibodies (mAbs), glycobiology ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo